These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 368654)

  • 1. Let us stop regulating DNA research.
    Watson JD
    Nature; 1979 Mar; 278(5700):113. PubMed ID: 368654
    [No Abstract]   [Full Text] [Related]  

  • 2. The recombinant-DNA debate.
    Grobstein C
    Sci Am; 1977 Jul; 237(1):22-33. PubMed ID: 331472
    [No Abstract]   [Full Text] [Related]  

  • 3. The recombinant DNA scenarios: Andromeda strain, chimera, and Golem.
    Davis BD
    Am Sci; 1977; 65(5):547-55. PubMed ID: 334004
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic manipulation: new guidelines for UK.
    Nature; 1978 Nov; 276(5684):104-8. PubMed ID: 283310
    [No Abstract]   [Full Text] [Related]  

  • 5. US proposes exemptions from DNA guidelines.
    Dickson D
    Nature; 1978 Aug; 274(5670):411. PubMed ID: 672968
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic manipulation: Britain may exempt "self-cloning".
    Walgate R
    Nature; 1979 Feb; 277(5698):589. PubMed ID: 370609
    [No Abstract]   [Full Text] [Related]  

  • 7. Environmental groups lose friends in effort to control DNA research.
    Marshall E
    Science; 1978 Dec; 202(4374):1265-9. PubMed ID: 725600
    [No Abstract]   [Full Text] [Related]  

  • 8. Will the DNA guidelines wither away?
    Nature; 1980 Oct; 287(5782):473-4. PubMed ID: 6999363
    [No Abstract]   [Full Text] [Related]  

  • 9. Six months in category four.
    Brenner S
    Nature; 1978 Nov; 276(5683):2-4. PubMed ID: 283309
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA: let the public choose.
    Wright S
    Nature; 1978 Oct; 275(5680):468. PubMed ID: 692727
    [No Abstract]   [Full Text] [Related]  

  • 11. WHO looks for benefits from genetic engineering.
    Newmark P
    Nature; 1978 Apr; 272(5655):663-4. PubMed ID: 347303
    [No Abstract]   [Full Text] [Related]  

  • 12. US expected to exempt most recombinant DNA experiments from federal regulation.
    Nature; 1979 Sep; 281(5727):90. PubMed ID: 471066
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk assessment protocols for recombinant DNA experimentation.
    J Infect Dis; 1978 May; 137(5):704-14. PubMed ID: 207789
    [No Abstract]   [Full Text] [Related]  

  • 14. US to increase public participation in regulation of DNA research.
    Dickson D
    Nature; 1978 Nov; 276(5687):430. PubMed ID: 723919
    [No Abstract]   [Full Text] [Related]  

  • 15. US drug companies push for changes in recombinant DNA guidelines.
    Dickson D
    Nature; 1979 Mar; 278(5703):385-6. PubMed ID: 450039
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulating recombinant DNA research: pulling back from the apocalypse.
    Lappé M
    Man Med; 1977; 2(2):103-9. PubMed ID: 12083132
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulating recombinant DNA research: pulling back from the apocalypse.
    Lappé M
    Not Man Apart; 1977 Jan; 7(1):7-8. PubMed ID: 11661389
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution of the NIH guidelines.
    Milewski EA
    Recomb DNA Tech Bull; 1981 Dec; 4(4):160-5. PubMed ID: 7029672
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant DNA is safe.
    Pritchard RH
    Nature; 1978 Jun; 273(5665):696. PubMed ID: 661976
    [No Abstract]   [Full Text] [Related]  

  • 20. OSHA looks at occupational regulations for recombinant DNA use.
    Nature; 1980 Feb; 283(5747):512. PubMed ID: 6986560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.